| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-5876(86)80075-1 |
| P8608 | Fatcat ID | release_gzrzajsiv5fotorheic5ypxtoe |
| P698 | PubMed publication ID | 3570684 |
| P2093 | author name string | Herndon DN | |
| Hall JW 3rd | |||
| Gary LB | |||
| Winkler JB | |||
| P2860 | cites work | Ototoxicity of Gentamicin in Man: A Survey and Controlled Analysis of Clinical Experience in the United States | Q50645402 |
| Iatrogenic ototoxic hearing loss. | Q50648913 | ||
| Observation of Click-Evoked Compound Viii Nerve Responses Before, During, And Over Seven Months After Kanamycin Treatment in the Guinea Pig | Q54002007 | ||
| Elimination Kinetics of Furosemide in Perilymph and Serum of the Chinchilla:Neuropharmacologic Correlates | Q54707686 | ||
| Cochlear damage resulting from kanamycin and furosemide | Q58082086 | ||
| Ototoxicity of aminoglycoside antibiotics in infants and children | Q61713353 | ||
| Inner ear damage induced by bacterial endotoxin | Q67274075 | ||
| A follow-up study on the cochlear, vestibular and renal function in children treated with gentamicin in the newborn period | Q69231643 | ||
| Pharmacokinetics of Gentamicin in Perilymph and Endolymph of the Rat as Determined by Radioimmunoassay | Q70766134 | ||
| Dual action of ototoxic antibiotics on sensory hair cells | Q72604158 | ||
| Controlled Comparison of Amikacin and Gentamicin | Q28324094 | ||
| Deafness and biochemical imbalance after burns treatment with topical antibiotics in young children. Report of 6 cases | Q28332207 | ||
| Ototoxicity of amikacin | Q28333609 | ||
| Permanent Deafness Associated with Furosemide Administration | Q28336512 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| Aminoglycoside ototoxicity in the human | Q34057509 | ||
| Vancomycin ototoxicity in patients with normal renal function | Q38582952 | ||
| The Cochlear Nuclei in Monkeys after Dihydro-Streptomycin or Noise Exposure | Q39379059 | ||
| Prevention of hearing impairment from infection and ototoxic drugs | Q39494691 | ||
| Why Monitor Serum Levels of Gentamicin? | Q39725314 | ||
| Hyperthermia increases aminoglycoside ototoxicity. | Q40837471 | ||
| Detection of Tobramycin- and Netilmicin-Induced Ototoxicity in Guinea Pigs with Evoked Action Potentials | Q41569193 | ||
| Comparative ototoxic liability of netilmicin and gentamicin | Q42111978 | ||
| The pharmacokinetics of amikacin in children | Q42118695 | ||
| Ototoxicity Induced by Furosemide | Q42238707 | ||
| Kanamycin Ototoxicity—Possible Potentiation by Other Drugs | Q42238712 | ||
| Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies | Q42256548 | ||
| Vancomycin Ototoxicity in a Patient with Normal Renal Function | Q42269595 | ||
| Vancomycin: a reappraisal. | Q42335492 | ||
| Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin | Q43770644 | ||
| Effects of perilymphatic perfusion with neomycin on the cochlear microphonic potential in the guinea pig. | Q45066609 | ||
| Alteration of aminoglycoside antibiotic ototoxicity by hyper- and hypohydration | Q46205404 | ||
| Predictability of blood levels of gentamicin in man | Q46702575 | ||
| Pediatric applications of serial auditory brainstem and middle-latency evoked response recordings | Q48468470 | ||
| Neuro-otologic applications of simultaneous multi-channel auditory evoked response recordings | Q48647696 | ||
| Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. | Q50589543 | ||
| The influence of ototoxic drugs on brainstem auditory evoked potentials in man. | Q50603774 | ||
| Immediate effects of intravenous tobramycin and gentamicin on human cochlear function. | Q50606127 | ||
| Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. | Q50622127 | ||
| Otologic symptoms in chronic renal failure. The possible role of aminoglycoside-furosemide interaction | Q50625655 | ||
| Hearing function and chronic renal failure | Q50628555 | ||
| P433 | issue | 2 | |
| P921 | main subject | ototoxicity | Q1351381 |
| P304 | page(s) | 187-203 | |
| P577 | publication date | 1986-12-01 | |
| P1433 | published in | International Journal of Pediatric Otorhinolaryngology | Q2602426 |
| P1476 | title | Auditory brainstem response in young burn-wound patients treated with ototoxic drugs | |
| P478 | volume | 12 |
| Q46255439 | ABR and DPOAE detection of cochlear damage by gentamicin |
| Q38676819 | Aminoglycoside-induced hearing loss in humans |
| Q48648710 | Assessment of cisplatin-induced ototoxicity using derived-band ABRs |
| Q37328789 | Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. |
| Q48354326 | High-frequency tone burst-evoked ABR latency-intensity functions |
| Q50521966 | High-frequency toneburst-evoked ABR latency-intensity functions in sensorineural hearing-impaired humans. |
| Q30466567 | Live cell imaging of a fluorescent gentamicin conjugate |
| Q33741753 | Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome |
| Q41006933 | Survival and therapy of burn patients at the threshold of the twenty-first century: a review |
| Q30502734 | Vancomycin- and erythromycin-induced hearing loss in humans |
Search more.